{"id":"https://openalex.org/W2096988077","doi":"https://doi.org/10.1200/jco.2003.11.077","title":"Early Molecular Response of Marrow Disease to Biologic Therapy Is Highly Prognostic in Neuroblastoma","display_name":"Early Molecular Response of Marrow Disease to Biologic Therapy Is Highly Prognostic in Neuroblastoma","publication_year":2003,"publication_date":"2003-10-10","ids":{"openalex":"https://openalex.org/W2096988077","doi":"https://doi.org/10.1200/jco.2003.11.077","mag":"2096988077","pmid":"https://pubmed.ncbi.nlm.nih.gov/14551304"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2003.11.077","doi":"https://doi.org/10.1200/jco.2003.11.077","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2003.11.077","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083817841","display_name":"Irene Y. Cheung","orcid":"https://orcid.org/0000-0002-1427-514X","observed_orcids":["https://orcid.org/0000-0002-1427-514X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene Y. Cheung","raw_affiliation_strings":["From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY","Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. Cheungi@mskcc.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. Cheungi@mskcc.org","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109218938","display_name":"M. S. Lo Piccolo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Serena Lo Piccolo","raw_affiliation_strings":["From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043729995","display_name":"Brian H. Kushner","orcid":"https://orcid.org/0000-0002-8916-0697","observed_orcids":["https://orcid.org/0000-0002-8916-0697"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian H. Kushner","raw_affiliation_strings":["From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034081882","display_name":"Nai\u2010Kong V. Cheung","orcid":"https://orcid.org/0000-0001-6323-5171","observed_orcids":["https://orcid.org/0000-0001-6323-5171"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nai-Kong V. Cheung","raw_affiliation_strings":["From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":3.4445,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.92053882,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"21","issue":"20","first_page":"3853","last_page":"3858"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.6480000019073486},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9129999876022339},{"id":"https://openalex.org/keywords/molecular-response","display_name":"molecular response","score":0.5109999775886536},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7730000019073486},{"id":"https://openalex.org/keywords/anti-gd2-immunotherapy","display_name":"anti-GD2 immunotherapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9570000171661377},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5600000023841858},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.703000009059906},{"id":"https://openalex.org/keywords/refractory-disease","display_name":"refractory disease","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8082116842269897},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.7481333017349243},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6730523109436035},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.663831353187561},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5778096914291382},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5500515699386597},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5087540745735168},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.47506874799728394},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4591509699821472},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4342237114906311},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.41896480321884155},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37254512310028076},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3709252178668976},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3415694236755371},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23496881127357483},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1157020628452301},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017350","descriptor_name":"N-Acetylgalactosaminyltransferases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019046","descriptor_name":"Bone Marrow Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2003.11.077","doi":"https://doi.org/10.1200/jco.2003.11.077","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2003.11.077","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:14551304","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14551304","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7898451521","display_name":"Molecular Detection of Occult Neuroblastoma","funder_award_id":"5r21ca095742-02","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G8147462882","display_name":null,"funder_award_id":"CA095742","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1515642134","https://openalex.org/W1565403166","https://openalex.org/W1575002436","https://openalex.org/W1821283949","https://openalex.org/W1825707388","https://openalex.org/W1844660989","https://openalex.org/W1901831739","https://openalex.org/W1915556294","https://openalex.org/W1940650862","https://openalex.org/W1960710326","https://openalex.org/W1972953239","https://openalex.org/W1976897003","https://openalex.org/W1998347916","https://openalex.org/W2007527741","https://openalex.org/W2051804704","https://openalex.org/W2063286298","https://openalex.org/W2080430937","https://openalex.org/W2083933004","https://openalex.org/W2096398040","https://openalex.org/W2097962804","https://openalex.org/W2122070299","https://openalex.org/W2140591503","https://openalex.org/W2151069914","https://openalex.org/W2159325547","https://openalex.org/W2166454117","https://openalex.org/W2168664911","https://openalex.org/W2172587361","https://openalex.org/W2187715826","https://openalex.org/W2280912529","https://openalex.org/W2327522594"],"related_works":["https://openalex.org/W2168664911","https://openalex.org/W2145003578","https://openalex.org/W2133929244","https://openalex.org/W2032982054","https://openalex.org/W2333090206","https://openalex.org/W2151310238","https://openalex.org/W2106514210","https://openalex.org/W2131419971","https://openalex.org/W2045350806","https://openalex.org/W1998347916"],"abstract_inverted_index":{"PURPOSE:":[0],"A":[1],"promising":[2],"treatment":[3,103],"strategy":[4],"for":[5,38,106,258],"stage":[6,51],"4":[7,52],"neuroblastoma":[8,53,249],"patients":[9,39,54,215],"is":[10,35,243,255],"the":[11,127,147,251],"repeated":[12],"application":[13],"of":[14,146,156,163,180,189,193,198,227,234,248,272],"anti-GD2":[15],"immunotherapy":[16],"after":[17],"activating":[18],"myeloid":[19],"effectors":[20],"with":[21,159,216],"granulocyte-macrophage":[22],"colony-stimulating":[23],"factor":[24],"(GM-CSF).":[25],"To":[26],"use":[27],"early":[28,270],"marrow":[29,97,144],"response":[30,246],"as":[31,268],"a":[32,223,231,244],"prognostic":[33],"marker":[34,171,247],"particularly":[36,256],"relevant":[37],"not":[40],"likely":[41],"to":[42,274],"benefit":[43],"from":[44,133],"this":[45],"therapy.":[46],"PATIENTS":[47],"AND":[48],"METHODS:":[49],"Eighty-six":[50],"older":[55],"than":[56],"1":[57],"year":[58],"at":[59,130,230],"diagnosis":[60],"were":[61,104,121],"classified":[62],"in":[63,142,178,250],"four":[64,148],"clinical":[65,149],"groups":[66,150,211],"on":[67,123],"protocol":[68,134],"entry:":[69],"complete":[70,181],"remission":[71,76,182],"or":[72,183],"very":[73,184],"good":[74,185],"partial":[75,186],"(n":[77,82,87,93],"=":[78,83,88,94],"33),":[79,84],"primary":[80,190],"refractory":[81,86],"secondary":[85,194],"10),":[89],"and":[90,101,118,154,167,196,209,263],"progressive":[91,199],"disease":[92,200,228,261],"10).":[95],"Bone":[96],"samples":[98,125,145],"collected":[99],"before":[100,126],"following":[102,174],"assayed":[105],"GD2":[107,137,240],"synthase":[108,138,241],"mRNA":[109,139,242],"by":[110],"real-time":[111],"reverse":[112],"transcriptase":[113],"polymerase":[114],"chain":[115],"reaction.":[116],"Response":[117],"survival":[119,203],"analyses":[120],"performed":[122],"posttreatment":[124],"third":[128],"cycle":[129],"1.8":[131],"months":[132,236],"entry.":[135],"RESULTS:":[136],"was":[140,204],"evident":[141],"pretreatment":[143],"(42%,":[151],"52%,":[152],"60%,":[153],"80%":[155],"samples,":[157],"respectively),":[158],"median":[160,232],"transcript":[161],"level":[162],"10.0,":[164],"16.6,":[165],"26.5,":[166],"87.2,":[168],"respectively.":[169],"This":[170],"became":[172],"negative":[173],"antibody":[175,275],"plus":[176,276],"GM-CSF":[177,277],"77%":[179],"remission,":[187],"45%":[188],"refractory,":[191,195],"25%":[192],"0%":[197],"group.":[201],"Progression-free":[202],"statistically":[205],"different":[206],"between":[207],"responder":[208],"nonresponder":[210],"(P":[212,237],"<.0001).":[213],"Among":[214],"minimal":[217,259],"residual":[218,260],"disease,":[219],"molecular":[220],"responders":[221],"had":[222],"significantly":[224],"lower":[225],"risk":[226],"progression":[229],"follow-up":[233],"29.8":[235],"=.0001).":[238],"CONCLUSION:":[239],"sensitive":[245],"bone":[252],"marrow.":[253],"It":[254],"useful":[257,267],"evaluation":[262],"may":[264],"potentially":[265],"be":[266],"an":[269],"predictor":[271],"resistance":[273],"immunotherapy.":[278]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}